{"org_id": "T001999427", "org_name_cn": "百奥泰生物制药股份有限公司", "org_short_name_cn": "百奥泰", "org_name_en": "Bio-Thera Solutions,Ltd.", "org_short_name_en": "BIO-THERA", "main_operation_business": "创新药和生物类似药研发。", "operating_scope": "　　药品研发（人体干细胞、基因诊断与治疗技术除外）;生物技术咨询、交流服务（我国稀有和特有的珍贵优良品种，国家保护的原产于我国的野生动、植物资源开发除外）;生物技术开发服务（我国稀有和特有的珍贵优良品种，国家保护的原产于我国的野生动、植物资源开发除外）;医学研究和试验发展（人体干细胞、基因诊断与治疗技术除外）;生物药品制造;药品零售", "district_encode": "440112", "org_cn_introduction": "百奥泰生物制药股份有限公司的主营业务是创新药和生物类似药研发。公司的主要产品是创新药和生物类似药，用于治疗肿瘤、自身免疫性疾病、心血管疾病以及其它危及人类生命或健康的重大疾病。", "legal_representative": "易贤忠", "general_manager": "李胜峰", "secretary": "鱼丹", "established_date": 1059321600000, "reg_asset": 414080000.0, "staff_num": 836, "telephone": "86-8620-32203528", "postcode": "510530", "fax": "86-8620-32203218", "email": "ir@bio-thera.com", "org_website": "www.bio-thera.com", "reg_address_cn": "广东省广州市黄埔区高新技术产业开发区科学城开源大道11号A6栋第五层", "reg_address_en": "1st & 2nd Floors\r\nBuilding 1\r\nNo. 18 Keji Avenue\r\nYuhang District\r\nHangzhou\r\nZhejiang\r\nChina", "office_address_cn": "广东省广州市黄埔区高新技术产业开发区科学城开源大道11号A6栋第五层", "office_address_en": "1st & 2nd Floors\r\nBuilding 1\r\nNo. 18 Keji Avenue\r\nYuhang District\r\nHangzhou\r\nZhejiang\r\nChina", "currency_encode": "019001", "currency": "CNY", "listed_date": 1582214400000, "provincial_name": "广东省", "actual_controller": "易良昱 (40.93%)，易贤忠 (4.21%)，关玉婵 (2.62%)", "classi_name": "民营企业", "pre_name_cn": "百奥泰生物科技(广州)有限公司", "chairman": "易贤忠", "executives_nums": 22, "actual_issue_vol": 60000000.0, "issue_price": 32.76, "actual_rc_net_amt": 1876199800.0, "pe_after_issuing": null, "online_success_rate_of_issue": 0.04666639, "affiliate_industry": {"ind_code": "BK0042", "ind_name": "生物制品"}}